1093980-57-4

Basic information

• Product Name: 1H-IMidazole, 1-(4-ethynyl-2-Methoxyphenyl)-4-Methyl-
• Synonyms: 1H-IMidazole, 1-(4-ethynyl-2-Methoxyphenyl)-4-Methyl-;1-(4-ethynyl-2-methoxyphenyl)-4-methyl-1H-imidazole
• CAS NO: 1093980-57-4
• Molecular Formula: C₁₃H₁₂N₂O
• Molecular Weight: 212.24718
• Mol File: 1093980-57-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-IMidazole, 1-(4-ethynyl-2-Methoxyphenyl)-4-Methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-IMidazole, 1-(4-ethynyl-2-Methoxyphenyl)-4-Methyl-(1093980-57-4)
• EPA Substance Registry System: 1H-IMidazole, 1-(4-ethynyl-2-Methoxyphenyl)-4-Methyl-(1093980-57-4)

Safety Data

• Hazardous Substances Data: 1093980-57-4(Hazardous Substances Data)

Upstream product

• 128495-46-5 4-fluoro-3-methoxybenzaldehyde 
• 870837-18-6 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde 
• 90965-06-3 dimethyl 1-(1-diazo-2-oxopropyl)phosphonate 

Downstream Products

• 1093975-82-6 1-(3-fluorobenzyl)-4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazole 
• 1093976-07-8 4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1-[3-(trifluoromethoxy)benzyl]-1H-1,2,3-triazole 
• 1093976-10-3 1-(3,5-dibromobenzyl)-4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazole 
• 1093975-68-8 8-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)quinoline 
• 1315141-37-7 C₂₃H₂₁N₇O 
• 1093975-72-4 3-[3-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)phenyl]-5-methyl-1,2,4-oxadiazole 
• 1093975-74-6 3-[4-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)phenyl]-5-methyl-1,2,4-oxadiazole 
• 1093975-99-5 4-{3-[4-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine 
• 1315141-38-8 C₂₂H₁₉N₅OS 
• 1315141-39-9 C₂₂H₁₉N₅OS 
• 1093975-49-5 2-(4-{4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-[1,2,3]triazol-1-ylmethyl}phenyl)benzooxazole 
• 1093975-43-9 1-(4-tert-butylbenzyl)-4-[3-methoxy-4-(4-methylimidazole-1-yl)-phenyl]-1H-[1,2,3]triazole 
• 1315141-30-0 C₁₇H₂₃N₅OSi 
• 1093976-13-6 1-benzyl-4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol 

Relevant articles and documents

Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys

Abstract Synthesis and SAR studies of novel triazolobenzazepinones as gamma secretase modulators (GSMs) are presented in this communication. Starting from our azepinone leads, optimization studies toward improving central lowering of Aβ42 led to the discovery of novel benzo-fused azepinones. Several benzazepinones were profiled in vivo and found to lower brain Aβ42 levels in Sprague Dawley rats and transgenic APP-YAC mice in a dose-dependent manner after a single oral dose. Compound 34 was further progressed into a pilot study in our cisterna-magna-ported rhesus monkey model, where we observed robust lowering of CSF Aβ42 levels.

Triazoloamides as potent γ-secretase modulators with reduced hERG liability

Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication. Starting from our aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams. Triazole 57 was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC 50 in cell-based assays and reduced affinity for the hERG channel.

Triazoles as γ-secretase modulators

Synthesis, SAR, and evaluation of aryl triazoles as novel gamma secretase modulators (GSMs) are presented in this communication. Starting from the literature and in-house leads, we evaluated a range of five-membered heterocycles as replacements for olefin

TRIAZOLE DERIVATIVES FOR TREATING ALZHEIMER'S DISEASE AND RELATED CONDITIONS

Compounds of formula I: Selectively attenuate production of Aβ(1-42) and hence find use in treatment or prevention of diseases associated with deposition of Aβ in the brain, in particular Alzheimer's disease.